If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Eliana Rulli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
oxaliplatin Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Glaucoma Medicine & Life Sciences
Colonic Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
trabectedin Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Meta-Analysis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

  • 3244 Citations
  • 25 h-Index
  • 109 Article
  • 1 Review article
1 Citation (Scopus)
coenzyme Q10
Ophthalmic Solutions
Open Angle Glaucoma
Vitamin E
Visual Fields

Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer

Colombo, N., Zaccarelli, E., Baldoni, A., Frezzini, S., Scambia, G., Palluzzi, E., Tognon, G., Lissoni, A. A., Rubino, D., Ferrero, A., Farina, G., Negri, E., Pesenti Gritti, A., Galli, F., Biagioli, E., Rulli, E., Poli, D., Gerardi, C., Torri, V., Fossati, R. & 1 others, D'Incalci, M., Sep 20 2019, In : British Journal of Cancer.

Research output: Contribution to journalArticle

trabectedin
Carboplatin
Platinum
Ovarian Neoplasms
Safety

Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma

the Italian Association of Neuro-Oncology, Silvani, A., De Simone, I., Fregoni, V., Biagioli, E., Marchioni, E., Caroli, M., Salmaggi, A., Pace, A., Torri, V., Gaviani, P., Quaquarini, E., Simonetti, G., Rulli, E. & D’Incalci, M., Jan 1 2019, In : Journal of Neuro-Oncology. 142, 3, p. 455-462

Research output: Contribution to journalArticle

Glioblastoma
temozolomide
Disease-Free Survival
IDN 5109
Recurrence

Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma

Italian Association of Neuro-Oncology, May 6 2019, In : Journal of Neuro-Oncology. 142, 3, p. 455-62 8 p.

Research output: Contribution to journalArticle

Glioblastoma
temozolomide
Disease-Free Survival
IDN 5109
Recurrence

Oral Prolonged-Release Oxycodone-Naloxone: Analgesic Response, Safety Profile, and Factors Influencing the Response in Patients With Advanced Cancer

Good Response with Appropriate Treatment (GREAT) Collaborators, Jan 1 2019, In : Pain Practice.

Research output: Contribution to journalArticle

Oxycodone
Naloxone
Analgesics
Constipation
Safety